Result Summary for S2WB2003
| Protocol ID: | S2WB2003 |
| Clinical Study ID: | S2WB2003 (S2WT50) |
| Official Title: | A double-blind, placebo-controlled, randomised, parallel group study to evaluate the safety and efficacy of oral naratriptan (5mg and 10mg) following dosing during a migraine attack. |
| Phase: | Phase 2 |
| Study Indications or Diseases: |
|
| Generic Name: | naratriptan |
| Trade/Product Name: | amerge;naramig |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
